Cargando…
Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling
Platelet-derived growth factor-BB (PDGF-BB) and its downstream effector, extracellular signal-regulated kinase 1/2 (ERK1/2) MAP kinase, initiate a multitude of biological effects, including vascular smooth muscle cell (VSMC) proliferation and migration, which are critical events in the initiation an...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271974/ https://www.ncbi.nlm.nih.gov/pubmed/25432005 http://dx.doi.org/10.3390/molecules191219501 |
_version_ | 1783377052752150528 |
---|---|
author | Sun, Lan Zhao, Rui Lan, Xi Chen, Ruoyun Wang, Si Du, Guanhua |
author_facet | Sun, Lan Zhao, Rui Lan, Xi Chen, Ruoyun Wang, Si Du, Guanhua |
author_sort | Sun, Lan |
collection | PubMed |
description | Platelet-derived growth factor-BB (PDGF-BB) and its downstream effector, extracellular signal-regulated kinase 1/2 (ERK1/2) MAP kinase, initiate a multitude of biological effects, including vascular smooth muscle cell (VSMC) proliferation and migration, which are critical events in the initiation and development of restenosis following percutaneous transluminal coronary angioplasty (PTCA). Styryl lactones are natural products that have been demonstrated to possess anti-proliferative activities. Goniolactone C is a styryl lactone derivative that was first extracted from Goniothalamus cheliensis Hu. In the present study, we investigated the effects of goniolactone C on VSMC migration and proliferation. We found that goniolactone C preferentially interacted with cellular systems that rely on PDGF signaling but not those that rely on epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) signaling. Goniolactone C strongly inhibited PDGF-BB-induced VSMC migration and proliferation. goniolactone C-mediated inhibition of VSMC proliferation was associated with cell cycle arrest, while goniolactone C-mediated inhibition of VSMC migration was associated with the suppression of adhesion molecule expression. In addition, goniolactone C directly inhibited PDGFR-β kinase activity, thereby blocking the downstream effector of PDGF-BB. Thus, the results of the present study suggest a novel adjunctive pharmacological strategy that may be used to prevent angioplasty-related restenosis. |
format | Online Article Text |
id | pubmed-6271974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62719742018-12-28 Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling Sun, Lan Zhao, Rui Lan, Xi Chen, Ruoyun Wang, Si Du, Guanhua Molecules Article Platelet-derived growth factor-BB (PDGF-BB) and its downstream effector, extracellular signal-regulated kinase 1/2 (ERK1/2) MAP kinase, initiate a multitude of biological effects, including vascular smooth muscle cell (VSMC) proliferation and migration, which are critical events in the initiation and development of restenosis following percutaneous transluminal coronary angioplasty (PTCA). Styryl lactones are natural products that have been demonstrated to possess anti-proliferative activities. Goniolactone C is a styryl lactone derivative that was first extracted from Goniothalamus cheliensis Hu. In the present study, we investigated the effects of goniolactone C on VSMC migration and proliferation. We found that goniolactone C preferentially interacted with cellular systems that rely on PDGF signaling but not those that rely on epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) signaling. Goniolactone C strongly inhibited PDGF-BB-induced VSMC migration and proliferation. goniolactone C-mediated inhibition of VSMC proliferation was associated with cell cycle arrest, while goniolactone C-mediated inhibition of VSMC migration was associated with the suppression of adhesion molecule expression. In addition, goniolactone C directly inhibited PDGFR-β kinase activity, thereby blocking the downstream effector of PDGF-BB. Thus, the results of the present study suggest a novel adjunctive pharmacological strategy that may be used to prevent angioplasty-related restenosis. MDPI 2014-11-26 /pmc/articles/PMC6271974/ /pubmed/25432005 http://dx.doi.org/10.3390/molecules191219501 Text en © 2014 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sun, Lan Zhao, Rui Lan, Xi Chen, Ruoyun Wang, Si Du, Guanhua Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling |
title | Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling |
title_full | Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling |
title_fullStr | Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling |
title_full_unstemmed | Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling |
title_short | Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling |
title_sort | goniolactone c, a styryl lactone derivative, inhibits pdgf-bb-induced vascular smooth muscle cell migration and proliferation via pdgfr/erk signaling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271974/ https://www.ncbi.nlm.nih.gov/pubmed/25432005 http://dx.doi.org/10.3390/molecules191219501 |
work_keys_str_mv | AT sunlan goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling AT zhaorui goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling AT lanxi goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling AT chenruoyun goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling AT wangsi goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling AT duguanhua goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling |